Pharm 1 Lectures 9 & 10: Conceptual Antimicrobial and Infectious Disease

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/42

encourage image

There's no tags or description

Looks like no tags are added yet.

43 Terms

1
New cards

antibiogram

how institutions track changes in antimicrobial resistance and to guide empirical antimicrobial therapy

<p><span>how institutions track changes in antimicrobial resistance and to guide empirical antimicrobial therapy</span></p>
2
New cards

susceptibility testing

tests susceptibility of pathogens to certain antimicrobials

3
New cards

Culture and Sensitivity (C&S)

lab test conducted to identify pathogens such as bacteria or fungi in a sample (blood, urine, pus, or other body fluids) and determine which antibiotics or antifungal medications are effective against them

4
New cards

minimal inhibitory concentration (MIC) on a C&S report

lowest antibiotic concentration that inhibits (not kills) growth of bacteria

single numerical value on a C&S report

lower MIC does not mean that one antibiotic is preferable to another

determines S (Susceptible), I (Intermediate/Increased Exposure), or R (Resistant)

5
New cards

C&S vs MIC

C&S report = the entire lab document identifying the pathogen, its growth, and its susceptibility to multiple drugs.

MIC = a specific measurement within that report, showing the lowest drug concentration that inhibits bacterial growth.

6
New cards

S, I, R interpretation

S (Susceptible), I (Intermediate/Increased Exposure), or R (Resistant), based on the Minimum Inhibitory Concentration (MIC)

S: antibiotic likely to work

I: likely to work if higher dose or higher frequency

R: antibiotic less likely to work

7
New cards

(T/F) Lower MIC means that one antibiotic is clinically preferable to another

False

8
New cards

concentration-dependent activity

antibiotics whose effect increases with the peak drug concentration, rather than with the duration of exposure above the MIC

9
New cards

time-dependent activity

antibiotics whose effect correlates with duration of time above MIC

10
New cards

superinfection

2nd infection by organism that is resistant to therapy that was given

Alteration of normal gut flora makes you more susceptible to infection

11
New cards

sepsis symptoms & timeline

fever, hypothermia, tachycardia/tachypenia, hypotension, altered mental status, organ dysfunction, clinical deterioration

if shock: start antimicrobials within 1 hr

without shock: within 3 hrs

12
New cards

gram negative bacteria

thin peptidoglycan layer, outer membrane present, pink

“-as” ending except Proteus and Haemophilus

13
New cards

gram positive bacteria

thick peptidoglycan layer, no outer membrane, purple

strep, staph, enterococcus, listeria

14
New cards

atypical bacteria (not gram pos or neg)

Chlamydia spp., Mycoplasma, Treponema pallidum, Rickettsia, Legionella

15
New cards

microbes in/on the body

knowt flashcard image
16
New cards

microbes found in URI

Moraxella

Haemophilus

S. pneumonia

17
New cards

microbes in oropharyngeal flora

Strep mitus/oralis

Streptococcus viridans

Anaerobes

Candida*

18
New cards

pathogens causing infections in vaginal tract

group B strep / S. agalactiae*

Candida*

19
New cards

microbes on skin flora

S. aureus*

Group A strep / S. pyogenes*

P. aeruginosa*

S. epidermidis

Candida

Diphtheroids

20
New cards

microbes in gut

Clostridioides Difficile*

anaerobes

Enterococcus

E. coli

Lactobacillus

21
New cards

time dependent

time above MIC is important

e.g. Beta-lactams

22
New cards

concentration dependent

higher drug concentrations improve killing of bacteria

e.g., Aminoglycosides, Tobramycin

23
New cards

AUC/MIC

represents total drug exposure relative to MIC

e.g., Vancomycin

24
New cards

bacteriostatic

prevents growth of bacteria

relies partially on functioning immune system

25
New cards

risk of broad spectrum antibiotic

may alter natural flora and lead to superinfection, especially C. difficile

e.g., Tetracycline

26
New cards

pros and cons of combination therapy

pros: broaden spectrum of coverage, synergistic, reduce dose of individual agents

cons: additive toxic effects, inactivation of one drug by another, antagonistic effects, $


*the exception, not the rule.

27
New cards

(t/f) Antibiotics are toxic

True

28
New cards

hospital acquired bugs hard to kill

Methicillin-resistant Staphylococcus aureus
Vancomycin-resistant Enterococcus faecium/faecalis
Clostridioides difficile

29
New cards

ESKAPE group of highly drug‑resistant bacteria

E – Enterococcus faecium (VRE)
S – Staphylococcus aureus (MRSA)
K – Klebsiella pneumoniae
A – Acinetobacter baumannii
P – Pseudomonas aeruginosa
E – Enterobacter species
(Not a complete list of resistance threats)

30
New cards

primary prophylaxis

  • low dose

  • narrow spectrum

  • e.g., Rifampin: miningococcal meningitis

  • e.g., macrolides: pertusis


31
New cards

preemptive therapy

  • infected but asymptomatic

  • replaces prophylaxis in high risk pts


32
New cards

empiric therapy

  • obtain cultures first (otherwise may mask Sx)

  • broad spectrum of antibacterial + antifungal


33
New cards

definitive therapy

  • narrow

  • usually not combination therapy


34
New cards

Which bacteria is the most common pathogen causing surgical site infections?

S. aureus

35
New cards

Rifampin

example of PEP; prevents meningococcal meningitis

36
New cards

examples of PEP

Rifampin: prevents meningococcal meningitis

Prevention of gonorrhea of syphilis

Macrolides after contact with confirmed pertusis

37
New cards

biofilms

makes it hard for antibiotics to penetrate

common on: artificial heart valves, long-dwelling catheters, artificial hips, devices for internal fixation of bone fractures

Staph Epidermidis most common. Can be S. Aureus.

38
New cards

pathogens commonly affecting immunosuppressed patients

• Pneumocystis jiroveci
• Mycobacterium avium-intracellulare
• Toxoplasma gondii
• Candida species
• Aspergillus species
• Cytomegalovirus and other Herpesviridae

39
New cards

how microbes develop resistance

• Degradation or modification of the antibiotic (e.g., beta-lactamases)
• Reduction in the bacterial antibiotic concentration by inhibiting entry
or by efflux pumps (fluoroquinolones, aminoglycosides, tetracyclines, B-lactams, macrolides)
• Modification of the antibiotic target
- Alterations of cell wall precursors (vancomycin and VRE)
- Changes in target enzymes (penicillin-binding proteins in the bacterial cell
wall)
- Alterations in the ribosomal binding sites (Abx that disrupt protein synthesis)

40
New cards

pathogens causing CAP

S. pneumoniae
H. influenzae
Moraxella catarrhalis
Atypicals (Legionella, Mycoplasma, Chlamydia)

41
New cards

pathogens causing HAP

S. pneumoniae
H. influenzae
Moraxella catarrhalis
Atypicals (Legionella, Mycoplasma, Chlamydia)

+
Pseudomonas
E. coli
Klebsiella
S. aureus (MSSA/MRSA)


(first 4 also cause CAP)

42
New cards

pathogens causing UTIs

E. coli (MC)

Staphylococcus Saprophyticus (honeymoon cystitis, second MC)
Klebsiella
Proteus
Enterococcus

43
New cards

pathogens causing cellulitis

Purulent skin infection or abscess: S. aureus, including MRSA
Nonpurulent: GBS MC. MSSA second MC.